OF SPECIAL INTEREST
Vorinostat approved for rare lymphoma
New drugs and dosage forms
Pharmacodynamics not likely to appear in antimicrobial labeling soon
Upcoming Meeting
Outcomes similar with first- and second-generation antipsychotics
FDA holds public meeting on nanotechnology
Patient care, research intertwined goals at St. Jude
News Briefs
Correction
Pharmacists' role in assessing potential value of CPOE
Physicians' awareness of nonapproved drug indications in Slovenia
Lessons learned from a medication error
Chempack program
A health policy fellowship
Coping with Medicare Part D's effects on patient assistance programs
Prasterone
Pharmacogenetics and irinotecan therapy
Assessment of adverse drug events among patients in a tertiary care medical center
Adverse drug reactions and therapeutic errors in older adults
Outcomes of recommendations by hospice pharmacists
Stability and viscosity of a flavored omeprazole oral suspension for pediatric use
Overview of radiopaque drugs
Use of problem-based learning in staff training and development
Searching for the Holy Grail of oncology
Blowing the whistle
Cancer Management
Chimborazo